Key result
Trypsin and thrombin stimulate aldosterone secretion in rat adrenal capsular tissue, an effect mediated by the activation of protease-activated receptor 1 (PAR-1) and phospholipase C.
The stimulation of aldosterone secretion by trypsin in the rat adrenal cortex is mediated by the activation of protease-activated receptor 1 (PAR-1).
May implicate PAR-1 in aldosterone regulation; leaves open relevance to human hypertension.
Stimulation of aldosterone by a serine protease, trypsin, was first reported in 1982, although the mechanism of this effect was unclear. Recently, a family of protease-activated receptors (PARs) has been described and four members of the family characterised and cloned, including the previously recognised thrombin receptor. This study investigated whether PARs mediate the action of trypsin on aldosterone secretion. Using intact rat adrenal capsular tissue, thrombin was found to increase aldosterone secretion, and the effects of trypsin on aldosterone secretion were confirmed. Both trypsin and thrombin were shown to activate phospholipase C, as measured by an increase in inositol triphosphate turnover by adrenal capsular tissue. It was also shown that U73122, a phospholipase C inhibitor, attenuated the aldosterone response to trypsin. These effects were consistent with the activation of a PAR. Northern blot analysis revealed the presence of mRNA encoding PAR-1, but not PARs-2, -3 or -4 in the adrenal capsule/zona glomerulosa. Messenger RNA encoding PAR-1 was increased by dietary sodium depletion, consistent with previous reports of an increased response to trypsin after sodium depletion. These data suggest that the actions of trypsin on aldosterone secretion are mediated by PAR-1.
No takes yet. Share an insight, caveat, or question.
Raven et al. (2001) studied Aldosterone secretion. Trypsin and thrombin was evaluated on Aldosterone secretion and phospholipase C activation. Trypsin and thrombin stimulate aldosterone secretion in rat adrenal capsular tissue, an effect mediated by the activation of protease-activated receptor 1 (PAR-1) and phospholipase C.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: